Entourage Health Corp. (ENTG.V)

CAD 0.01

(0.0%)

Total Debt Summary of Entourage Health Corp.

Entourage Health Corp.'s latest annual total debt in 2023 was 161.58 Million CAD , up 20.1% from previous year.
Entourage Health Corp.'s latest quarterly total debt in 2024 Q2 was 174.77 Million CAD , up 4.01% from previous quarter.
Entourage Health Corp. reported annual total debt of 134.53 Million CAD in 2022, up 27.69% from previous year.
Entourage Health Corp. reported annual total debt of 105.36 Million CAD in 2021, up 30.27% from previous year.
Entourage Health Corp. reported quarterly total debt of 174.77 Million CAD for 2024 Q2, up 4.01% from previous quarter.
Entourage Health Corp. reported quarterly total debt of 161.58 Million CAD for 2023 Q4, up 4.1% from previous quarter.

Annual Total Debt Chart of Entourage Health Corp. (2023 - 2014)

Historical Annual Total Debt of Entourage Health Corp. (2023 - 2014)

Year	Total Debt	Total Debt Growth
2023	161.58 Million CAD	20.1%
2022	134.53 Million CAD	27.69%
2021	105.36 Million CAD	30.27%
2020	80.87 Million CAD	69.19%
2019	47.8 Million CAD	0.0%
2018	- CAD	-100.0%
2017	11.35 Million CAD	77.62%
2016	6.39 Million CAD	10901.81%
2015	58.09 Thousand CAD	0.0%
2014	- CAD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	168.03 Million CAD	3.99%
2024 Q2	174.77 Million CAD	4.01%
2023 Q4	161.58 Million CAD	4.1%
2023 FY	161.58 Million CAD	20.1%
2023 Q1	154.13 Million CAD	14.57%
2023 Q2	148.94 Million CAD	-3.36%
2023 Q3	155.21 Million CAD	4.21%
2022 Q2	116.28 Million CAD	9.56%
2022 Q4	134.53 Million CAD	12.56%
2022 FY	134.53 Million CAD	27.69%
2022 Q1	106.13 Million CAD	0.74%
2022 Q3	119.51 Million CAD	2.78%
2021 Q3	80.76 Million CAD	2.04%
2021 FY	105.36 Million CAD	30.27%
2021 Q1	79.67 Million CAD	-1.48%
2021 Q2	79.15 Million CAD	-0.66%
2021 Q4	105.36 Million CAD	30.45%
2020 Q4	80.87 Million CAD	0.39%
2020 FY	80.87 Million CAD	69.19%
2020 Q3	80.56 Million CAD	65.18%
2020 Q2	48.77 Million CAD	0.66%
2020 Q1	48.45 Million CAD	1.37%
2019 Q3	45.43 Million CAD	25.37%
2019 FY	47.8 Million CAD	0.0%
2019 Q4	47.8 Million CAD	5.2%
2019 Q1	35.43 Million CAD	0.0%
2019 Q2	36.24 Million CAD	2.29%
2018 Q4	- CAD	-100.0%
2018 FY	- CAD	-100.0%
2018 Q3	2.36 Million CAD	3.8%
2018 Q1	8.61 Million CAD	-24.07%
2018 Q2	2.27 Million CAD	-73.61%
2017 Q1	7.2 Million CAD	12.79%
2017 Q2	- CAD	-100.0%
2017 Q3	- CAD	0.0%
2017 Q4	11.35 Million CAD	0.0%
2017 FY	11.35 Million CAD	77.62%
2016 FY	6.39 Million CAD	10901.81%
2016 Q4	6.39 Million CAD	1278090.2%
2016 Q2	- CAD	0.0%
2016 Q1	- CAD	-100.0%
2016 Q3	500.00 CAD	0.0%
2015 Q4	58.09 Thousand CAD	0.0%
2015 Q3	- CAD	0.0%
2015 FY	58.09 Thousand CAD	0.0%
2015 Q2	- CAD	0.0%
2015 Q1	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q3	- CAD	0.0%

Peer Total Debt Comparison of Entourage Health Corp.

Name	Total Debt	Total Debt Difference
Aequus Pharmaceuticals Inc.	5.06 Million CAD	-3090.932%
CanadaBis Capital Inc.	7.3 Million CAD	-2110.63%
Decibel Cannabis Company Inc.	40.96 Million CAD	-294.448%
Delivra Health Brands Inc.	2.02 Million CAD	-7871.468%
Lifeist Wellness Inc.	1.26 Million CAD	-12663.003%
Cannara Biotech Inc.	45.78 Million CAD	-252.926%
Medicure Inc.	544 Thousand CAD	-29602.512%
PharmaCielo Ltd.	18.3 Million CAD	-782.542%
Rubicon Organics Inc.	10.25 Million CAD	-1474.937%
BioSyent Inc.	1.22 Million CAD	-13133.064%
Voyageur Pharmaceuticals Ltd.	40 Thousand CAD	-403854.16%